Actis planned to acquire 25% stake in Symbiotec Pharmalab. Actis, a private equity firm based in London, was looking to acquire a stake in Symbiotec Pharmalab.
Tags: Foreign Investment Promotion Board
Pharma major GSK seeks FIPB nod to hike stake in Indian subsidiary
GlaxoSmithKline has asked for the approval of India's Foreign Investment Promotion Board for its planned acquisition of a 24.33% stake in its Indian arm GlaxoSmithKline Pharmaceuticals Ltd. GSK will fund the stake hike by investing INR6,400 crore.
Tesco-Tata-owned Trent Hypermarket joint venture gets green light from Indian regulator
British retailer Tesco's $110 million investment in Tata-owned Trent Hypermarket has received approval from India's Department of Industry Policy and Promotion (DIPP). This will pave the way for Tesco to get a clearance from the country's Foreign Investment Promotion Board (FIPB).
Tesco to invest $110 million in Indian joint venture with Tata Group
British retailer Tesco said it had applied with India's Foreign Investment Promotion Board to acquire a 50% stake in a joint venture with Tata Group. Tesco intends to invest $110 million in the partnership.
India approves Swedish retailer H&M's USD115 million investment
India's Foreign Investment Promotion Board has given the green light to Hennes & Mauritz's (H&M) INR7.2 billion (USD115 million) investment. The Swedish retail-clothing company looks to open 50 stores in India.
Latest News
1
